Specific BACE1 genotypes provide additional risk for late-onset Alzheimer disease in APOE ε4 carriers

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 119 B, Issue 1, 2003, Pages 44-47

  Gold, Gabriel ^a   Blouin, Jean Louis ^b   Herrmann, François R ^a   Michon, Agnès ^a   Mulligan, Reinhild ^a   Saïl, Geneviève Duriaux ^b   Bouras, Constantin ^a   Giannakopoulos, Panteleimon ^a,c   Antonarakis, Stylianos E ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c Belle Idée   (Switzerland)

Author keywords

Alzheimer disease; APOE 4; APP; BACE1; BACE2; Secretase

Indexed keywords

APOLIPOPROTEIN E; BETA SECRETASE; BETA SECRETASE 1; BETA SECRETASE 2; GENE PRODUCT; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 11Q; CHROMOSOME 21Q; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RANDOMIZATION; RISK FACTOR; SENILE PLAQUE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0041318900     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.10010     Document Type: Article

References (25)

1. Annaert WG, Levesque L, Craessaerts K, Dierinck I, Snellings G, Westaway D, George-Hyslop PS, Cordell B, Fraser P, De Strooper B. 1999. Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons. J Cell Biol 147:277-294.
2. Checler F. 1995. Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease. J Neurochem 65:1431-1444.
3. Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, Johnson-Wood K, Lee M, Seubert P, Davis A, Kholodenko D, Motter R, Sherrington R, Perry B, Yao H, Strome R, Lieberburg I, Rommens J, Kim S, Schenk D, Fraser P, St. George Hyslop P, Selkoe DJ. 1997. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 3:67-72.
4. Cruts M, Dermaut B, Rademakers R, Roks G, Van den Broeck M, Munteanu G, van Duijn CM, Van Broeckhoven C. 2001. Amyloid beta secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease. Neurosci Lett 313:105-107.
5. Hardy J. 1994. Alzheimer's disease: the present situation and our tasks. Neurobiol Aging 15(Suppl): 111-112.
6. Herrmann F, Mermod J-J, Henderson S, Michel J. 1999. Epidemiology of dementia in Geneva. In: Michel J-P, Hof PR, editors. Management of aging. The University of Geneva experience. Vol. 30: Interdisciplinary topics in gerontology. Basel: Karger. p 94-100.
7. Hof PR, Morrison JH. 1994. The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions. in: Terry RD, Katzman R, Bick KL, editors. Alzheimer disease. New York: Raven Press. p 197-229.
8. Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, Gloger IS, Murphy KE, Southan CD, Ryan DM, Smith TS, Simmons DL, Walsh FS, Dingwall C, Christie G. 1999. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci 14:419-427.
9. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B. 1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733-736.
10. Lin X, Koelsch G, Wu S, Downs D, Dashti A, Tang J. 2000. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl Acad Sci USA 97:1456-1460.
11. McKhann G, Drachman DA, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services task force on Alzheimer's disease. Neurology 34:939-944.
12. Mulligan R, Juillerat Van der Linden AC, Di Pollina L. Evaluation and diagnosis at the Memory Clinic of Geneva. In: Michel J-P, Hof PR, editors. Management of aging. The University of Geneva Experience. Vol 30: Interdisciplinary Topics in Gerontology. Basel: Karger. p 113-123.
13. Murphy T, Yip A, Brayne C, Easton D, Evans JG, Xuereb J, Cairns N, Esiri MM, Rubinsztein DC. 2001. The BACE gene: genomic structure and candidate gene study in late-onset Alzheimer's disease. Neuroreport 12:631-634.
14. Nicolaou M, Song YQ, Sato CA, Orlacchio A, Kawarai T, Medeiros H, Liang Y, Sorbi S, Richard E, Rogaev EI, Moliaka Y, Bruni AC, Jorge R, Percy M, Duara R, Farrer LA, St. Georg-Hyslop P, Rogaeva EA. 2001. Mutations in the open reading frame of the beta-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer's disease. Neurogenetics 3:203-206.
15. Nowotny P, Kwon JM, Chakraverty S, Nowotny V, Morris JC, Goate AM. 2001. Association studies using novel polymorphisms in BACE1 and BACE2. Neuroreport 12:1799-1802.
16. Richards B, Skoletsky J, Shuber AP, Balfour R, Stern RC, Dorkin HL, Parad RB, Witt D, Klinger KW. 1993. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet 2:159-163.
17. Roses AD. 1998. Alzheimer diseases: a model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases Am J Med Genet 81:49-57.
18. Saunders AM, Schmader K, Breitner JC, Benson MD, Brown WT, Goldfarb L, Goldgaber D, Manwaring MG, Szymanski MH, McCown N, et al. 1993. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342:710-711.
19. Saunders AJ, T-W K, Tanzi RE, Fan W, Bennett DB, Babu-Kahn S, Luo Y, Louis J-C, McCaleb M, Citron M, Vassar R, Richards WG. 1999. BACE maps to chromosome 11 and a BACE homolog, BACE2, reside in the obligate Down Syndrome region of chromosome 21. Science 286:1255a.
20. Selkoe DJ. 2001. Alzheimer's disease: genes, proteins and therapy. Physiol Rev 81:741-766.
21. Shuber AP, Skoletsky J, Stern R, Handelin BL. 1993. Efficient 12-mutation testing in the CFTR gene: a general model for complex mutation analysis. Hum Mol Genet 2:153-158.
22. Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M, Dovey HF, Frigon N, Hong J, Jacobson-Croak K, Jewett N, Keim P, Knops J, Lieberburg I, Power M, Tan H, Tatsuno G, Tung J, Schenk D, Seubert P, Suomensaari SM, Wang S, Walker D, John V, et al. 1999. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402:537-540.
23. Tanzi RE, Bertram L. 2001. New frontiers in Alzheimer's disease genetics. Neuron 32:181-184.
24. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M. 1999. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735-741.
25. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, Brashier JR, Stratman NC, Mathews WR, Buhl AE, Carter DB, Tomasselli AG, Parodi LA, Heinrikson RL, Gurney ME. 1999. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402:533-537.